Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombotic Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06534021
What this trial is testing

IASO-782 in Autoimmune Hematological Diseases

Who this might be right for
Autoimmune ThrombocytopeniaWarm Autoimmune Haemolytic Anaemia
Shanghai IASO Biotechnology Co., Ltd 16
Large-scale testing (Phase 3)Study completedNCT05220878
What this trial is testing

Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With ITP

Who this might be right for
Idiopathic Thrombocytopenic Purpura
AO GENERIUM 160
Not applicableStudy completedNCT02248610
What this trial is testing

Follow-up in Rivaroxaban Patients in Setting of Thromboembolism

Who this might be right for
Venous Thromboembolism
King's College Hospital NHS Trust 1,343
Large-scale testing (Phase 3)Study completedNCT02063789
What this trial is testing

An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Green Cross Corporation 81
Testing effectiveness (Phase 2)UnknownNCT05232149
What this trial is testing

Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
Beijing InnoCare Pharma Tech Co., Ltd. 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07196163
What this trial is testing

An Exploratory Study of Golidocitinib in Adult Patients With ITP

Who this might be right for
Immune Thrombocytopenia (ITP)
Peking University People's Hospital 138
Large-scale testing (Phase 3)Study completedNCT01520909
What this trial is testing

Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.

Who this might be right for
Idiopathic Thrombocytopenic Purpura
GlaxoSmithKline 92
Testing effectiveness (Phase 2)Study completedNCT04534114
What this trial is testing

Factor XI LICA to Reduce Events Such as Heart Attack and Stroke in Patients Whose Kidneys Are no Longer Able to Work as They Should and Require Treatment to Filter Wastes From the Blood: Focus is on the Safety of BAY2976217 and the Way the Body Absorbs, Distributes and Removes the Study Drug

Who this might be right for
End Stage Renal Disease Requiring Hemodialysis
Bayer 307
Not applicableLooking for participantsNCT05937828
What this trial is testing

OBS'CEREVANCE: French Cohort of Pediatric Autoimmune Cytopenia

Who this might be right for
Immune ThrombocytopeniaAutoimmune Hemolytic AnemiaEvans Syndrome
University Hospital, Bordeaux 3,500
Testing effectiveness (Phase 2)Study completedNCT00010387
What this trial is testing

Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease

Who this might be right for
Anemia, Hemolytic, AutoimmuneFelty SyndromePurpura, Thrombocytopenic+1 more
Johns Hopkins University 32
Large-scale testing (Phase 3)Study completedNCT04670432
What this trial is testing

Resolution Enhancement by a Supplemental Obstruction Lessening Venoactive Drug for Eight Weeks in Deep Vein Thrombosis

Who this might be right for
Deep Vein Thrombosis
Maastricht University Medical Center 44
Not applicableEnded earlyNCT03968276
What this trial is testing

Study of the Interest of Patients Undergoing Anti-thrombotic Treatment in a Digital Application of Therapeutic Assistance

Who this might be right for
Vascular Diseases
Fondation Hôpital Saint-Joseph 25
Not applicableUnknownNCT03885180
What this trial is testing

Randomized Evaluation of D-dimer Guiding dUration of Oral antiCoagulation thErapy

Who this might be right for
Valve Heart DiseaseAnticoagulants; Increased
Wuhan Asia Heart Hospital 500
Large-scale testing (Phase 3)Ended earlyNCT00991939
What this trial is testing

Initial Treatment of Patients With Immune Thrombocytopenic Purpura

Who this might be right for
Immune Thrombocytopenic Purpura
Carelon Research 8
Testing effectiveness (Phase 2)Ended earlyNCT03866577
What this trial is testing

Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients

Who this might be right for
Immune Thrombocytopenic Purpura (ITP)
Momenta Pharmaceuticals, Inc. 50
Not applicableNot Yet RecruitingNCT07426107
What this trial is testing

Development and Prospective Validation of an AI Model for Prognosis in ITP Patients Undergoing Coronary Revascularization

Who this might be right for
Immune Thrombocytopenic PurpuraCoronary Artery Disease
Xiao Hui Zhang 600
Post-approval studies (Phase 4)Study completedNCT04250116
What this trial is testing

Appropriate Duration of Anti-Platelet and Thrombotic Strategy After 12 Months in Patients With Atrial Fibrillation Treated With Drug Eluting Stents

Who this might be right for
Atrial Fibrillation
Yonsei University 960
Not applicableStudy completedNCT01971684
What this trial is testing

ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP

Who this might be right for
Immune Thrombocytopenia
Boston Children's Hospital 120
Not applicableUnknownNCT02583971
What this trial is testing

Assessment of Thrombotic Status in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
East and North Hertfordshire NHS Trust 500
Large-scale testing (Phase 3)Ended earlyNCT03205995
What this trial is testing

Safety and Efficacy Study of OMS721 in Patients With Atypical Hemolytic Uremic Syndrome

Who this might be right for
Thrombotic MicroangiopathiesAtypical Hemolytic Uremic Syndrome
Omeros Corporation 6
Next Page